The Regan Group at Morgan Stanley

Call Directions Website Contact the business

The Regan Group at Morgan Stanley Financial Advisors at Morgan Stanley
NMLS # 1410252
NMLS # 1646393
CA License #4020916 MSSB is not responsible for content posted by third-parties.

©2026 Morgan Stanley Smith Barney LLC (‘MSSB’), Member SIPC (www.sipc.org), reserves the right, under applicable law, to retain and monitor all electronic communications. MSSB will not accept page purchase or sale orders via social network messaging systems. MSSB does not provide tax or legal advice. MSSB Financial Advisors may only transact business, provide individualized responses, or render personalized investment advice for compensation in states where they are registered or excluded or exempted from registration https://brokercheck.finra.org/. Designations or awards are not indicative of a Financial Advisor's past or future performance, and no fee is paid in exchange for such. The information on this profile does not provide personalized investment advice and is not an offer to buy or sell any security, open a particular account, or to engage in any investment strategy. All content is for US residents only and subject to the following terms: http://www.morganstanley.com/disclaimers/mswm-email.html, https://www.morganstanley.com/disclosures/social-media-important-information. NMLS #: 1410252
NMLS #: 1646393
CA Insurance License #: 4020916

With AI startups scaling at record speed, our analysts Sabrina Hao, Adam Wood and Brian Nowak share takeaways from Morga...
10/29/2026

With AI startups scaling at record speed, our analysts Sabrina Hao, Adam Wood and Brian Nowak share takeaways from Morgan Stanley's Spark Conference on AI returns, competitive moats and implications for public markets.
Listen here:

morganstanley.com

In this episode of Exceptional Leaders, Morgan Stanley's Head of Life Science Tools and Diagnostics Research, Kallum Tit...
10/21/2026

In this episode of Exceptional Leaders, Morgan Stanley's Head of Life Science Tools and Diagnostics Research, Kallum Titchmarsh, visits Thermo Fisher's biologics and gene-therapy manufacturing facility in Plainville, Massachusetts, for a conversation with the company's Chairman and CEO Marc Casper.
Watch here:

morganstanley.com

Our Global Head of Fixed Income Research Andrew Sheets examines what rising rates could mean for equity valuations, earn...
10/19/2026

Our Global Head of Fixed Income Research Andrew Sheets examines what rising rates could mean for equity valuations, earnings and investor appetite.
Listen here:

morganstanley.com

How healthcare leaders are navigating patent expirations, healthcare M&A and AI adoption to shape the future of the indu...
10/16/2026

How healthcare leaders are navigating patent expirations, healthcare M&A and AI adoption to shape the future of the industry.
Read more here:

morganstanley.com

AI's next wave may reward companies using the technology most effectively—not just those building it. Here's what invest...
10/14/2026

AI's next wave may reward companies using the technology most effectively—not just those building it. Here's what investors can watch as AI moves toward profits.
Read more here:

morganstanley.com

Our CIO and Chief U.S. Equity Strategist Mike Wilson breaks down how the market is transitioning to a mid-cycle environm...
10/12/2026

Our CIO and Chief U.S. Equity Strategist Mike Wilson breaks down how the market is transitioning to a mid-cycle environment, with leadership shifting toward higher-quality, asset-light companies with durable earnings.
Listen here:

morganstanley.com

New innovations around diseases including Alzheimer's. The growing reach of GLP-1 therapies. AI's ability to accelerate ...
10/01/2026

New innovations around diseases including Alzheimer's. The growing reach of GLP-1 therapies. AI's ability to accelerate drug development and reduce costs. See what is top of mind for 3,000 investors and leaders from the biopharmaceutical, biotechnology, medical services and health services sectors.
Find more here:

morganstanley.com

The rise of agentic AI is increasing demand for tools capable of identifying and governing non-human access, which could...
09/29/2026

The rise of agentic AI is increasing demand for tools capable of identifying and governing non-human access, which could more than double the market for identity security.
Read more here :

morganstanley.com

U.S. consumers' increasing appetite for energy drinks and beverage shops is fueling growth that outpaces the rest of the...
09/24/2026

U.S. consumers' increasing appetite for energy drinks and beverage shops is fueling growth that outpaces the rest of the food and beverages sector.
Read more here:

morganstanley.com

Investors have plenty to digest this month, from economic data to central-bank decisions. Our Global Head of Fixed Incom...
09/22/2026

Investors have plenty to digest this month, from economic data to central-bank decisions. Our Global Head of Fixed Income Research outlines what could drive the next bout of volatility.
Listen here:

morganstanley.com

Address

340 Mt. Kemble Avenue, 1st Floor
Morristown, NJ
07960

Alerts

Be the first to know and let us send you an email when The Regan Group at Morgan Stanley posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to The Regan Group at Morgan Stanley:

Shortcuts

Share